Skip to content

SAD and MAD of VENT-02 in healthy volunteers

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2023-505546-26-00
Enrollment
86
Registered
2023-07-20
Start date
2023-07-21
Completion date
2024-04-17
Last updated
2024-03-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neuroinflammatory and neurodegenerative diseases

Interventions

None listed

Sponsors

Ventus Therapeutics U.S. Inc.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

Netherlands

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026